Selective targeting of liver cancer with the endothelial marker CD146.
about
Evaluation of CD146 as Target for Radioimmunotherapy against OsteosarcomaCD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinomaReduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.Impact of wall shear stress and ligand avidity on binding of anti-CD146-coated nanoparticles to murine tumor endothelium under flow.High-throughput flow cytometry screening of human hepatocellular carcinoma reveals CD146 to be a novel marker of tumor-initiating cells.
P2860
Selective targeting of liver cancer with the endothelial marker CD146.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Selective targeting of liver cancer with the endothelial marker CD146.
@ast
Selective targeting of liver cancer with the endothelial marker CD146.
@en
Selective targeting of liver cancer with the endothelial marker CD146.
@nl
type
label
Selective targeting of liver cancer with the endothelial marker CD146.
@ast
Selective targeting of liver cancer with the endothelial marker CD146.
@en
Selective targeting of liver cancer with the endothelial marker CD146.
@nl
prefLabel
Selective targeting of liver cancer with the endothelial marker CD146.
@ast
Selective targeting of liver cancer with the endothelial marker CD146.
@en
Selective targeting of liver cancer with the endothelial marker CD146.
@nl
P2093
P2860
P356
P1433
P1476
Selective targeting of liver cancer with the endothelial marker CD146.
@en
P2093
Alexandr V Bazhin
Eduard Ryschich
Peter Schemmer
Stefan Thomann
Thomas Longerich
P2860
P304
P356
10.18632/ONCOTARGET.2345
P407
P50
P577
2014-09-01T00:00:00Z